Hirudoid Forte

Hirudoid Forte is a topical preparation that contains the active ingredient mucopolysaccharide polysulfuric acid ester, a heparinoid compound. Although the exact strength and dosage form are not publicly disclosed, the product is marketed in the European Union for external use on the skin. It is classified as a topical anti‑inflammatory and antithrombotic agent, designed to improve microcirculation and aid the resolution of superficial bruises, oedema and related conditions.

Hirudoid Forte is indicated for several superficial vascular and inflammatory skin conditions where improved microcirculation and reduced swelling are desired. The formulation is applied externally to the affected area and is commonly used in clinical practice for managing minor vascular disorders and trauma‑related skin changes. - Superficial thrombophlebitis (inflammation of superficial veins) - Bruising and haematomas resulting from minor trauma - Localised oedema associated with venous stasis - Inflammatory skin conditions such as dermatitis - Venous stasis and varicose vein discomfort - Post‑operative swelling and bruising after minor surgical procedures

Topical application of Hirudoid Forte may be associated with local skin reactions and, rarely, systemic effects that warrant monitoring.

Common: - Mild skin irritation or erythema at the application site - Pruritus (itching) localized to the treated area - Transient burning or stinging sensation upon first use - Dryness or peeling of the skin - Localized swelling reduction may be accompanied by a feeling of tightness - Temporary discoloration (hyperpigmentation) of the skin - Slight tingling sensation that resolves within minutes

Serious: - Allergic contact dermatitis with vesiculation - Extensive bruising or hematoma expansion unrelated to trauma - Systemic anticoagulant effect leading to abnormal bleeding - Severe skin necrosis (very rare) - Unexplained systemic bruising or hemorrhage

When using Hirudoid Forte, certain precautions should be observed to minimize the risk of adverse reactions and ensure safe application. - Avoid applying to broken, infected, or ulcerated skin. - Do not use on large surface areas without medical supervision. - Keep the product away from eyes, mucous membranes and open wounds. - Discontinue use if signs of allergic reaction develop. - Consult a healthcare professional before use during pregnancy or lactation. - Use with caution in patients receiving systemic anticoagulants. - Store at room temperature, protected from moisture and direct sunlight.

Topical heparinoids can interact with other agents applied to the skin or systemic medications that affect coagulation.

Avoid: - Avoid concurrent use with other topical anticoagulant or antiplatelet preparations (e.g., heparin cream, aspirin gel). - Do not combine with strong irritant or sensitizing dermatological products (e.g., retinoids, benzoyl peroxide).

Use with caution: - Use with caution in patients taking oral anticoagulants (warfarin, direct oral anticoagulants) as systemic absorption may increase bleeding risk. - Apply cautiously when using systemic corticosteroids, which may alter skin integrity. - Monitor for increased bruising when combined with non‑steroidal anti‑inflammatory drugs (NSAIDs) applied topically. - Discuss with a physician before using on extensive areas in individuals with clotting disorders.